Heart Lung Machine is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 53% of Heart Lung Machine and made more than 56% of revenue share in 2015. MAQUET followed as second produced about 13% in 2015.
Through the above research we tend to believe that Sorin is the most important player in the market and it will occupy a major share of the market in the future. The competition will become more intense, companies will play more and more attention to developing regions in the future.

The global Advanced Perfusion System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Advanced Perfusion System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Advanced Perfusion System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Advanced Perfusion System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Advanced Perfusion System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sorin
MAQUET
Medtronic
Terumo
Braile Biomedica
Tianjin Medical
Getinge
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Single Roller Pump Heart Lung Machine
Double Roller Pump Heart Lung Machine

Segment by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Other